The non-peptide neurokinin-1 antagonist, RPR 100893, decreases c-fos expression in trigeminal nucleus caudalis following noxious chemical meningeal stimulation

Neuroscience

Volumn 64, Issue 3, 1995, Pages 741-750

  Cutrer, F M ^a   Moussaoui, S ^b   Garret, C ^b   Moskowitz, M A ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b SANOFI   (France)

Author keywords

[No Author keywords available]

Indexed keywords

4 (2 METHOXYPHENYL) 2 [2 (2 METHOXYPHENYL)PROPIONYL] 7,7 DIPHENYLPERHYDROISOINDOL 4 OL; 4 (2 METHOXYPHENYL) 2 [2 (2 METHOXYPHENYL)PROPIONYL] 7,7 DIPHENYLPERHYDROISOINDOL 4 ONE; CAPSAICIN; NEUROKININ 1 RECEPTOR; NEUROKININ 1 RECEPTOR ANTAGONIST; TACHYKININ RECEPTOR ANTAGONIST; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN STEM; CONTROLLED STUDY; ENANTIOMER; GENE EXPRESSION; GUINEA PIG; INTRAVENOUS DRUG ADMINISTRATION; MALE; MENINX; NONHUMAN; ONCOGENE C FOS; PRIORITY JOURNAL; SPINAL CORD; TRIGEMINAL NUCLEUS;

ANIMAL; BLOOD PROTEINS; CAPSAICIN; GUINEA PIGS; INDOLES; MALE; MENINGES; PAIN; PROTO-ONCOGENE PROTEINS C-FOS; RECEPTORS, NEUROKININ-1; SUBSTANCE P; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TRIGEMINAL NUCLEI;

EID: 0028869867     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/0306-4522(94)00428-8     Document Type: Article

References (55)

1. 125I]Bolton Hunter derivatives of eledoisin and substance P in the rat brain
2. 1 receptors by use of the non-peptide antagonist, CP-96,345
3. 1 antagonist, (±)-CP-96,345, produces antinociceptive and anti-oedema effects in the rat
4. The tachykinins a family of peptides with a brood of “receptors”
5. Isolation of sialogogic peptide from bovine hypothalamic tissue and its characterization as substance P
6. Autoradiographic localization and characterization of spinal cord substance P binding sites: high densities in sensory, autonomic, phrenic and Onuf's motor nuclei
7. CP-96,345, a non-peptide antagonist of substance P. III. Cardiovascular effects in mammals unrelated to actions on substance P receptors
8. Substance P: localization, concentration and release in cerebral arteries, choroid plexus and dura mater
9. Bootstrap methods another look at the jackknife
10. 1 receptor
11. In vitro pharmacological profile of RPR 100893, a novel non-peptide antagonist of the human NK1 receptor
12. Antinociceptive properties and inhibition of neurogenic inflammation with potent SP antagonists belonging to perhydroisoindolones
13. Substance P and inflammatory pain: potential of substance P antagonists as analgesics
14. Induction of c-fos-like protein in spinal cord neurons following sensory stimulation
15. Stimulation of the superior sagittal sinus in the cat evokes c-fos expression in the caudal medulla and upper cervical spinal cord
16. Origin of fibers innervating the basilar artery of the cat
17. Innervation of the posterior fossa dura of the cat
18. 1 receptor antagonist, on facilitation of a nociceptive spinal flexion reflex in the rat
19. 1 tachykinin receptors in thermonociception: effect of (±)-CP-96,345, a non-peptide substance P antagonist, on the hot-plate test in mice
20. Multiple tachykinin binding sites in peripheral tissues and in brain
21. Oral or parenteral non-peptide NK1 receptor antagonist RPR 100893 blocks neurogenic plasma extravasation within guinea-pig dura mater and conjunctiva
22. Primary afferent and GABAergic synaptic input to NK-1 receptor (NK-1R) laden neurons in the dorsal horn of the rat spinal cord demonstrated by triple label EM immunocytochemistry (ICC)
23. Immunohistochemical evidence for a substance P-containing trigeminovascular pathway to pial arteries in cats
24. 3H]SP as the radioligand
25. Perivascular meningeal projection from cat trigeminal ganglia: possible pathway for vascular headache in man
26. Trigeminal projections to supratentorial pial and dural blood vessels in cats demonstrated by horseradish peroxidase histochemistry
27. Spinal and trigeminal projections to the nucleus of the solitary tract: a possible substrate for somatovisceral and visovisceral reflex activation
28. The expression of c-fos protein in presumed-nociceptive interneurons and projection neurons of the rat spinal cord: anatomical mapping of the central effects of noxious somatic, articular and visceral stimulation
29. 1 receptor: characterization and localization in the spinal cord
30. 1 receptor
31. 1 receptor
32. 1 receptor antagonist, RP 67580
33. The role of neurokinin and N-methyl-d-aspartate receptors in synaptic transmission from capsaicin sensitive primary afferent in the rat spinal cord in vitro
34. Differential localization of tachykinin receptors in rat spinal cord
35. Expression of c-fos-like immunoreactivity in brainstem after meningeal irritation by blood in the subarachnoid space
36. CP-93,129, sumatriptan, dihydroergotamine block c-fos expression within rat trigeminal nucleus caudalis caused by chemical stimulation of the meninges
37. Origins and distribution of cerebrovascular nerve fibers showing calcitonin gene-related peptide-like immunoreactivity in the major cerebral artery of the dog
38. Systemic morphine suppresses noxious stimulus-evoked fos protein-like immunoreactivity in the rat spinal cord
39. Multiple neurokinin receptors: recent developments
40. Pharmacological receptors for substance P and neurokinins
41. Selectivity and specificity of new, non-peptide, quinuclidine antagonists of substance P
42. 1 receptor antagonists: non-specific effects of racemic RP 67580
43. 1 receptor antagonist, RP 67580, blocks neurogenic plasma extravasation in the dura mater of rats
44. 1) receptor
45. The sensory representation of the dura mater in the trigeminal ganglion of the cat
46. 1 antagonists: the triarylperhydroisoindols
47. Cerebral arterial innervation by nerve fibers containing calcitonin gene-related peptide (CGRP): I. Distribution and origin of CGRP perivascular innervation in the rat
48. Innervation of the feline cerebral vasculature by nerve fibers containing calcitonin gene-related peptide: trigeminal origin and coexistence with substance P
49. Focal ischemia in rats causes time-dependent expression of c-fos protein immunoreactivity in widespread regions of ipsilateral cortex
50. Non-specific actions of the non-peptide tachykinin receptor antagonists, CP-96,345, RP 67580 and SR 48968, on neurotransmission
51. The differential role of substance P and neurokinin A in spinal cord hyperexcitability and neurogenic inflammation
52. A comparison of several dose levels with a zero dose control
53. Intrathecal CP-96,345 blocks reflex facilitation induced in rats by substance P and C-fiber-conditioning stimulation
54. On the role of NK-2 tachykinin receptors in the mediation of spinal reflex excitability in the rat
55. Quantitative autoradiographic distribution of multiple neurokinin binding sites in rat spinal cord